Q4 2021 Celyad Oncology SA Earnings Call Transcript

Mar 25, 2022 / 12:00PM GMT
Operator

Welcome to the Celyad Oncology second half 2021 earnings conference call. (Operator Instructions) Please note this event is being recorded. I'd now like to turn the conference over to Dan Ferry, Managing Director with LifeSci Advisors. Please go ahead, sir.

Dan Ferry - LifeSci Advisors - IR

Thank you all for joining us today. Before we begin, I would like to remind everyone that today's event may contain forward-looking statements within the meaning of applicable securities laws, including the Private Securities Litigation Reform Act of 1995. Forward-looking statements may involve known and unknown risks and uncertainties, which may cause actual results, financial condition, performance or achievements of the Company to differ materially from those expressed or implied by such forward-looking statements. A list and description of these risks, uncertainties and other risks can be found in the company's US Securities and Exchange Commission filings and reports, including in its annual report on Form 20-F, filed with the SEC on March 24, 2022, and subsequent filings

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot